{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:55:01Z","timestamp":1784260501578,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Over the last decade, expanding use of molecular diagnostics in heart transplantation has allowed implementation of non-invasive surveillance strategies for monitoring allograft health. The commercially available HeartCare platform combines the AlloMap gene expression profiling assay and the AlloSure donor-derived cell-free DNA test (dd-cfDNA). Beyond their established use for assessment of rejection, evidence is building for predictive utility, with the longitudinal AlloMap Variability score previously shown to correlate with the risk of future rejection, graft dysfunction, re-transplantation, or death. In this single-center, retrospective pilot study, we evaluated the performance of a novel AlloSure Variability metric in predicting mortality in a cohort of heart transplant\u00a0recipients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy-two adult heart transplant recipients with at least 3 concurrent AlloMap\/AlloSure results were included. Demographic, clinical, imaging, and laboratory parameters were captured. Variability was defined as the standard deviation of longitudinal AlloMap\/AlloSure results. A Cox multivariable adjusted proportional hazards model was used to evaluate the variability metrics as predictors of mortality. Associations between AlloMap\/AlloSure variability and donor specific antibody (DSA) status were also\u00a0assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5 patients (6.9%) died during a median follow-up of 480 days. In a univariate Cox proportional hazards model, higher AlloSure variability (HR 1.66, 95%CI 1.14 \u2013 2.41), but not AlloMap variability or the cross-sectional AlloSure\/AlloMap results was associated with increased mortality risk. Longitudinal AlloSure variability was also higher among patients with both preformed DSA and those developing <jats:italic>de novo<\/jats:italic> DSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that increased variability of dd-cfDNA in heart transplant patients is associated with both mortality risk and the presence of donor specific antibodies. These findings highlight the added value of longitudinal data in the interpretation of AlloMap\/AlloSure scores in this population and open the door to larger studies investigating the utility of these metrics in shaping post-transplant clinical care paradigms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.825108","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T09:23:28Z","timestamp":1645176208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients \u2013 A Proof-of-Concept Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Megan","family":"Kamath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoriy","family":"Shekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Silacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hairapetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanny","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galyna","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario C.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the Care of Heart Transplant Recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn"},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/23808993.2021.1840273","article-title":"The Evolution of Patient-Specific Precision Biomarkers to Guide Personalized Heart-Transplant Care","volume":"6","author":"Deng","year":"2021","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-Expression Profiling for Rejection Surveillance After Cardiac Transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12872-015-0106-1","article-title":"Performance of Gene-Expression Profiling Test Score Variability to Predict Future Clinical Events in Heart Transplant Recipients","volume":"15","author":"Crespo-Leiro","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000443897.29951.cf","article-title":"Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients","volume":"97","author":"Deng","year":"2014","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013924108","article-title":"Universal Noninvasive Detection of Solid Organ Transplant Rejection","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-Free DNA and Active Rejection in Kidney Allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late Manifestation of Alloantibody-Associated Injury and Clinical Pulmonary Antibody-Mediated Rejection: Evidence From Cell-Free DNA Analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive Detection of Graft Injury After Heart Transplant Using Donor-Derived Cell-Free DNA: A Prospective Multicenter Study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002482","article-title":"Donor-Specific Cell-Free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-Free DNA to Detect Heart Allograft Acute Rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-Derived Cell-Free DNA Predicts Allograft Failure and Mortality After Lung Transplantation","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"EBioMedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"s0085-2538(21)01168-6","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Validation and Clinical Outcome in Assessing Donor-Derived Cell-Free DNA Monitoring Insights of Kidney Allografts With Longitudinal Surveillance (ADMIRAL) Study","author":"Bu","year":"2021","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.03.007","article-title":"Cell-Free DNA Beyond a Biomarker for Rejection: Biological Trigger of Tissue Injury and Potential Therapeutics","volume":"40","author":"Tsuji","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.206","article-title":"Kidney Paired Donation in the Presence of Donor-Specific Antibodies","volume":"84","author":"Blumberg","year":"2013","journal-title":"Kidney Int"},{"key":"B18","unstructured":"TherneauTM\n            AtkinsonEJ\n          An Introduction to Recursive Partitioning Using the RPART Routines2019"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1016\/j.healun.2019.01.723","article-title":"Does Cell-Free DNA Detect the Development of De Novo Donor Specific Antibodies","volume":"38","author":"Kobashigawa","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14402","article-title":"Association Between dd-cfDNA Levels, De Novo Donor Specific Antibodies, and eGFR Decline: An Analysis of the DART Cohort","volume":"35","author":"Sawinski","year":"2021","journal-title":"Clin Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002333","article-title":"Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients","volume":"102","author":"Zhang","year":"2018","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40472-019-00257-y","article-title":"Heart Retransplantation: Candidacy, Outcomes, and Management","volume":"7","author":"Barghash","year":"2020","journal-title":"Curr Transplant Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T09:23:31Z","timestamp":1645176211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2022.825108"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.825108","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"825108"}}